Marrow fibrosis in myeloma: improvement by alkylating agent therapy.
Patterson
K G
KG
Department of Haematology, Middlesex Hospital, London.
Treleaven
J G
JG
Zuiable
A
A
D000477:Alkylating Agents / Q000627:therapeutic use*; D001706:Biopsy; D001853:Bone Marrow / Q000473:pathology; D006801:Humans; D008558:Melphalan / Q000627:therapeutic use; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications* / Q000188:drug therapy; D011239:Prednisolone / Q000627:therapeutic use; D055728:Primary Myelofibrosis / Q000150:complications* / Q000188:drug therapy / Q000473:pathology
D000477:Alkylating Agents; D011239:Prednisolone; D008558:Melphalan